Companies
Bring It On: Meet the Cannabis CMO Welcoming Scrutiny With Open Arms
Scrutiny of the UK’s medical cannabis industry has rarely, if ever, been so acute since it was legalised in 2018.
Ben Stevens
April 17, 2026
Scrutiny of the UK’s medical cannabis industry has rarely, if ever, been so acute since it was legalised in 2018.
Over the last few weeks, the UK’s medical cannabis industry has been written about in The Times, The Guardian, the
UK medical cannabis clinic Releaf has launched a new 24/7 on-demand legal support service for its prescribed patients, helping navigate
On 6 January 2026, the National Police Chiefs’ Council (NPCC) approved the first official guidance on medical cannabis for officers
The UK’s health service is fighting to keep its head above water, yet with a record-breaking winter flu pandemic sweeping
Despite being the second-largest and one of the most mature medical cannabis markets in Europe, the UK still falls well
UK clinic Releaf expands into Germany, leveraging its digital health ecosystem to capture market share in Europe’s fast-growing medical cannabis sector.
Releaf, a leading UK medical cannabis clinic, has announced the launch of a new global expansion strategy as it prepares
In this special edition of the Business of Cannabis Podcast, Tim Kirby, CEO of Releaf, sits down with Professor Chris Shambrook, renowned performance psychologist and long-time advisor to the British Olympic rowing team.
The UK’s Border Force and airport security services have been on high alert for cannabis coming into and out of
The British Medical Association (BMA), which represents tens of thousands of General Practitioners in the UK, this week threatened new
In this special edition of the Business of Cannabis Podcast, we go From Anecdote to Evidence with Dr Anne
Medical cannabis clinics are often driven to scale their operations quickly, out of a desire to reach more patients who could benefit from treatment and the need to remain affordable for them. But doing so shouldn’t come at the cost of regulatory compliance.
The third in our series of guest episodes features a discussion between the CEO of Releaf, Tim Kirby, and Robert Jappie, a partner at Fieldfisher LLP specialising in regulatory law.
With Germany recently making some foundational changes to its medical cannabis framework, helping expand access significantly and driving a surge in patient numbers, we spoke to leading UK-based clinic Releaf to understand what structural, cultural, and clinical lessons the UK can learn from Germany’s success.
From Germany’s coalition agreement to the expansion of the Netherlands’ cannabis pilot and the Czech Republic’s medical cannabis market, industry news has managed to match the heady pace of the global news cycle.
The second in our series of guest episodes features a discussion between CEO of Releaf, Tim Kirby, and James Duckenfield,
The medical cannabis industry is in a precarious situation. The fledgling market is experiencing rapid growth across Europe, indicative of
We won’t spam you